The Street’s Key Stock Analysts Research Reports
$AMD, $ARGX, $BIO, $BRKR, $CAT, $CHD, $CLX, $CL, $DO, $EL, $FITB, $FBP
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Friday, as follows:
Advanced Micro Devices Inc. (NASDAQ:AMD) Stifel reiterated AMD as Buy and raised the price target to $38 from $21.
arGEN-X N.V. (NASDAQ:ARGX) was added to the Best Ideas List at Wedbush Securities, with the firm noting an increasing confidence in efgartigimod’s broad market opportunity in antibody-mediated autoimmune diseases.
Bio-Rad Laboratories Inc. (NYSE:BIO) analysts started as Equal Weight at Morgan Stanley.
Bruker Corp. (NASDAQ:BRKR) analysts downgraded to Underweight from Equal Weight and the target price was raised to $32 from $31 at Morgan Stanley.
Caterpillar Inc. (NYSE: CAT) was raised to Outperform from Neutral with a 191 price target at Robert W. Baird. Caterpillar has a 166.50 consensus target price, and the 52-wk trading range is 123.62 – 173.24.
Church & Dwight Co. (NYSE:CHD) analysts started with an Overweight rating at Atlantic Equities.
Clorox Co. (NYSE:CLX) was started as Neutral at Atlantic Equities.
Colgate-Palmolive Co. (NYSE:CL) was started as Neutral at Atlantic Equities.
Diamond Offshore Drilling Inc. (NYSE:DO) was raised to Outperform from Sector Perform with a 23 price target at RBC Capital Markets. Shares have a 52-wk range of 13.00 – 21.92.
Estee Lauder Companies Inc. (NYSE:EL) was started with an Overweight rating at Atlantic Equities. The stock has a 52-wk trading range of 106.00 – 158.50. EL is my long time ‘lipstick’ economic indicator and it is Very Bullish now.
Fifth Third Bancorp (NASDAQ:FITB) analysts added FITB to the Wedbush Best Ideas List, with the firm noting several earnings levers that other banks don’t have to overcome, like a rebound in loan growth and less margin benefit from rate hikes as deposit costs are accelerating.
First Bancorp (NYSE:FBP) was raised to Buy from Neutral with an 11.50 price objective at Merrill Lynch.
Have a terrific weekend
Latest posts by Paul Ebeling (see all)
- The Fed Made a Mistake Hiking Rates in December, and Has Admitted It - March 25, 2019
- Ferrari (NYSE:RACE) Built This 1-Off Supercar for Anonymous Client - March 25, 2019
- Key US Treasury Yields Lowest Since December 2017 - March 25, 2019